- Home
- AUPH vs NYAX Comparison
AUPH vs NYAX Comparison
Compare AUPH & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- NYAX
- Stock Information
- Founded
- AUPH 1993
- NYAX 2005
- Country
- AUPH Canada
- NYAX Israel
- Employees
- AUPH N/A
- NYAX N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- NYAX
- Sector
- AUPH Health Care
- NYAX
- Exchange
- AUPH Nasdaq
- NYAX Nasdaq
- Market Cap
- AUPH 1.1B
- NYAX 1.7B
- IPO Year
- AUPH 1999
- NYAX N/A
- Fundamental
- Price
- AUPH $8.86
- NYAX $43.59
- Analyst Decision
- AUPH Strong Buy
- NYAX Buy
- Analyst Count
- AUPH 2
- NYAX 6
- Target Price
- AUPH $11.50
- NYAX $41.67
- AVG Volume (30 Days)
- AUPH 1.9M
- NYAX 21.1K
- Earning Date
- AUPH 07-31-2025
- NYAX 08-06-2025
- Dividend Yield
- AUPH N/A
- NYAX N/A
- EPS Growth
- AUPH N/A
- NYAX N/A
- EPS
- AUPH 0.27
- NYAX 0.18
- Revenue
- AUPH $247,295,000.00
- NYAX $331,161,000.00
- Revenue This Year
- AUPH $12.15
- NYAX $33.44
- Revenue Next Year
- AUPH $18.31
- NYAX $23.74
- P/E Ratio
- AUPH $33.04
- NYAX $245.78
- Revenue Growth
- AUPH 29.20
- NYAX 34.05
- 52 Week Low
- AUPH $5.20
- NYAX $20.31
- 52 Week High
- AUPH $10.67
- NYAX $52.46
- Technical
- Relative Strength Index (RSI)
- AUPH 64.10
- NYAX 41.33
- Support Level
- AUPH $7.36
- NYAX $42.88
- Resistance Level
- AUPH $9.10
- NYAX $52.46
- Average True Range (ATR)
- AUPH 0.44
- NYAX 1.30
- MACD
- AUPH 0.10
- NYAX -0.89
- Stochastic Oscillator
- AUPH 89.53
- NYAX 7.46
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About NYAX Nayax Ltd.
Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.